EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway

Zhen Zhang, Delong Niu, Wenjie Qiu, Haoyu Feng, Lurong Jia, Wenjuan Zhou

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-18

DOI: 10.2147/dddt.s599539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Zhen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Binzhou Medical University, Yantai, 264003, People's Republic of China. Hauptthemen laut MEDLINE: Osteoblasts, Ferroptosis, Periodontitis, Glucagon-Like Peptides. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is a major risk factor for periodontitis, often leading to exacerbated alveolar bone loss. Ferroptosis, an iron-dependent regulated cell death pathway, contributes to osteoblast dysfunction under diabetic conditions. The non-canonical Wnt5a/Ror2 pathway is pivotal in inflammation and bone metabolism. Semaglutide, a long-acting GLP-1 receptor agonist, may modulate this pathway and protect osteoblasts from ferroptosis, however, its role in diabetic periodontitis remains unclear.

Methods

MC3T3-E1 osteoblasts were exposed to high glucose plus palmitic acid (HGHP) to mimic a diabetic microenvironment. The effects of Semaglutide on osteoblast proliferation, migration, differentiation, mineralization, and ferroptosis were assessed using EDU, Transwell, ALP and ARS staining, qPCR, Western blotting, ROS, Fe 2 ⁺, and lipid peroxidation assays. Mechanistic involvement of Wnt5a/Ror2/p38 MAPK signaling was examined using Wnt5a siRNA and a p38 MAPK agonist. In vivo, T2DM mice with ligature-induced periodontitis were treated with semaglutide; alveolar bone and ferroptosis-related markers were assessed by H&E, immunohistochemistry (OPN, GPX4), and 4-HNE immunofluorescence.

Results

HGHP induced osteoblast ferroptosis, increased oxidative stress, and impaired osteogenic function. Semaglutide restored proliferation and osteogenic capacity and attenuated oxidative stress and ferroptosis. Wnt5a was upregulated by HGHP; its silencing reduced ferroptosis and improved osteogenesis. Semaglutide suppressed HGHP-induced Wnt5a/Ror2/p38 MAPK activation, whereas p38 activation blunted its protective effects. In T2DM periodontitis mice, semaglutide reduced periodontal inflammation and osteoblast ferroptosis.

Conclusion

Semaglutide mitigates HGHP-induced osteoblast ferroptosis and improves osteogenic function via the Wnt5a/Ror2/p38 MAPK pathway, supporting its potential in diabetic periodontitis. Keywords: semaglutide, diabetic periodontitis, ferroptosis, Wnt5a/Ror2, p38 MAPK pathway

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoblastsFerroptosisPeriodontitisGlucagon-Like PeptidesDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalSemaglutideAnimalsp38 Mitogen-Activated Protein KinasesWnt-5a ProteinMiceReceptor Tyrosine Kinase-like Orphan ReceptorsMice, Inbred C57BLMaleDose-Response Relationship, DrugCells, CulturedSignal Transduction

Stichwörter der Autor:innen

Wnt5a/Ror2diabetic periodontitisferroptosisp38 MAPK pathwaysemaglutide

Substanzen

Semaglutidep38 Mitogen-Activated Protein KinasesWnt-5a ProteinRor2 protein, mouseGlucagon-Like PeptidesReceptor Tyrosine Kinase-like Orphan ReceptorsWnt5a protein, mouse

Autor:innen und Institutionen

  • School of Stomatology, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Department of Stomatology, Lanzhou Petrochemical General Hospital (The Fourth affiliated Hospital of Gansu University of Chinese Medicine), Lanzhou, 730060, People's Republic of China.
  • Department of Oral Implantology, The Affiliated Yantai Stomatological Hospital, Binzhou Medical University, Yantai, 264003, People's Republic of China.

Zitieren

APA

Zhang, Z., Niu, D., Qiu, W., Feng, H., Jia, L., & Zhou, W. (2026). Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway. Drug Design, Development and Therapy, Volume 20, 1-18. https://doi.org/10.2147/dddt.s599539

Vancouver

Zhang Z, Niu D, Qiu W, Feng H, Jia L, Zhou W. Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-18. doi:10.2147/dddt.s599539

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhen and Niu, Delong and Qiu, Wenjie and Feng, Haoyu and Jia, Lurong and Zhou, Wenjuan},
  title = {Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--18},
  doi = {10.2147/dddt.s599539}
}
Kostenlos starten →